Document is current
Any future updates will be listed below
-
Authors
Epstein, Robert https://orcid.org/0000-0001-5031-302X
Krenitsky, JoAnn https://orcid.org/0000-0002-9627-6727
Sarocco, Phillip https://orcid.org/0009-0006-0893-9348
-
Funding
Funding for this research was provided by:
Halozyme
- License Information
-
More Information
Article History
Received: 15 April 2025
Accepted: 25 June 2025
First Online: 16 July 2025
Declarations
:
: Robert Epstein is co-founder, CEO, and President of Epstein Health, LLC. JoAnn Krenitsky is co-founder and SVP of Epstein Health, LLC. Phillip Sarocco is an employee and shareholder of Halozyme Therapeutics, Inc.
: Institutional review board (IRB) approval was obtained prior to patient recruitment; the final survey document and research plan received IRB review exemption by the Sterling IRB. This research was conducted according to the Helsinki Declaration. All HIPAA/patient privacy requirements were followed for patient recruitment, communication, obtaining and analyzing data, and by the participating personnel/facilities. All participants provided consent prior to participating in the online survey.
